A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204)

被引：0
|
作者：
Tada, H
Katoh, H
Kunitoh, H
Tsuboi, M
Asamura, H
Nagai, K
Mitsudomi, T
Koike, T
Ishizuka, N
Saijoh, N
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Tokyo Med Coll, Tokyo 160, Japan
[3] Natl Canc Ctr, Tokyo 104, Japan
[4] Natl Canc Ctr E, Kashiwa, Chiba, Japan
[5] Niigata Canc Ctr, Niigata, Japan
[6] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
[7] Int Med Ctr Japan, Tokyo, Japan
[8] Natl Canc Ctr E, Kashiwa, Chiba, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80175-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207
    Tsukada, H.
    Yokoyama, A.
    Nishiwaki, Y.
    Shinkai, T.
    Harada, M.
    Ando, M.
    Shibata, T.
    Ohe, Y.
    Tamura, T.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer
    Movsas, Benjamin
    Langer, Corey J.
    Ross, Helen J.
    Wang, Luhua
    Jotte, Robert M.
    Feigenberg, Steve
    Xu, Feng
    Huang, Chao H.
    Monberg, Matthew J.
    Obasaju, Coleman K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 673 - 679
  • [23] Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma: Results of the Japan Clinical Oncology Group study JCOG 0604.
    Tahara, Makoto
    Fuse, Nozomu
    Mizusawa, Junki
    Sato, Akihiro
    Nihei, Keiji
    Kanato, Keisuke
    Kato, Ken
    Yamazaki, Kentaro
    Muro, Kei
    Takaishi, Hiromasa
    Boku, Narikazu
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [24] Docetaxel in combination with either cisplatin or gemcitabine in unresectable non-small cell lung carcinoma: A randomized phase II study by the Japan Lung Cancer Cooperative Clinical Study Group
    Katakami, Nobuyuki
    Takiguchi, Yuichi
    Yoshimori, Kozo
    Isobe, Hiroshi
    Bessho, Akihiro
    Yoshimura, Akinobu
    Niitani, Hisanobu
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) : 447 - 453
  • [25] DOCETAXEL (D) VERSUS DOCETAXEL/GEMCITABINE (D&G) IN THE TREATMENT OF OLDER PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): AN ALPE ADRIA THORACIC ONCOLOGY MULTIDISCIPLINARY GROUP RANDOMIZED PHASE II TRIAL (ATOM 017)
    Rijavec, E.
    Belvedere, O.
    Aita, M.
    Rossetto, C.
    Follador, A.
    Sacco, C.
    Ceschia, T.
    Genova, C.
    Fasola, G.
    Grossi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S87 - S87
  • [26] Docetaxel (D) versus docetaxel/gemcitabine (D&G) in the treatment of older patients with advanced non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary Group randomized phase II trial (ATOM 017)
    Rijavec, E.
    Belvedere, O.
    Aita, M.
    Rossetto, C.
    Follador, A.
    Sacco, C.
    Ceschia, T.
    Pronzato, P.
    Fasola, G.
    Grossi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Randomized Phase II Trial of Zoledronic Acid in Combination With Docetaxel in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients With Bone Metastases - Result of a West Japan Oncology Group Study
    Hirai, F.
    Murakami, H.
    Yamamoto, N.
    Yamanaka, T.
    Okamoto, I.
    Sawa, T.
    Hirashima, T.
    Takeda, K.
    Fukuoka, M.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S628 - S628
  • [28] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [29] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
  • [30] Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984).
    Manegold, C
    Biesma, B
    Smit, H
    Van Meerbeeck, J
    Debruyne, C
    Legrand, C
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 657S - 657S
12345